A UCLA cancer research team has recently received a $7.6 million grant from the California Institute for Regenerative Medicine. This award will support research into genetically engineered white blood cells which can selectively target and kill tumor cells, while simultaneously activating other immune cells to do the same.Read More
Updated 12/8/2016, originally posted by Laura Braden 2/2/16
Understanding what stem cells do and why they are important has been a popular research topic for many years. Scientists have learned quite a bit about their functions, such as repairing damaged tissues and renewing some normal ones. However, there is no knowledge of where these stem cells originate and how they develop in the embryo.Read More
Funded in part by grants from the California Institute for Regenerative Medicine and the NIH, researchers at the University of California, San Diego have come up with a simple, easily repeated RNA-based technique of generating human induced pluripotent stem cells (iPSCs). The study was published in the August 1st edition of Cell Stem Cell. The researchers’ method has wide-ranging applications for others searching for new cell therapies and use in other stem cell studies.